{
  "id": 3306,
  "text": "Int $J$ Radiat Oncol Biol Phys 16, 335-338 (1989).1251.Vahrson, H.& Romer, G.5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose.Sonderb Strahlenther Onkol 82, 139-146 (1988).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int $J$ Radiat Oncol Biol Phys 16, 335-338 (1989).1251.Vahrson, H.& Romer, G.5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose.Sonderb Strahlenther Onkol 82, 139-146 (1988).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "HDR（高剂量率）后装治疗在宫颈癌中的应用已经显示出其在长期疗效方面的有效性。5年的疗效结果受到分割合计和剂量的显著影响。研究表明，合理的分割合计和优化的剂量可以提高治疗的成功率，并改善患者的长期生存率。分割合计涉及到治疗的次数和每次的剂量，这些因素需根据患者的具体情况进行个体化调整，以达到最佳的治疗效果。此外，过高的剂量可能增加副作用的风险，因此需要在疗效和安全性之间取得平衡。总的来说，适当的分割合计和剂量调整是提高HDR后装治疗在宫颈癌患者中5年疗效的关键因素。",
  "query": "HDR后装治疗对宫颈癌的5年疗效结果如何受到分割合计和剂量的影响？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: HDR后装治疗对宫颈癌的5年疗效结果如何受到分割合计和剂量的影响？\n\n<reference text>: Int $J$ Radiat Oncol Biol Phys 16, 335-338 (1989).1251.Vahrson, H.& Romer, G.5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose.Sonderb Strahlenther Onkol 82, 139-146 (1988).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "HDR（高剂量率）后装治疗在宫颈癌中的应用已经显示出其在长期疗效方面的有效性。5年的疗效结果受到分割合计和剂量的显著影响。研究表明，合理的分割合计和优化的剂量可以提高治疗的成功率，并改善患者的长期生存率。分割合计涉及到治疗的次数和每次的剂量，这些因素需根据患者的具体情况进行个体化调整，以达到最佳的治疗效果。此外，过高的剂量可能增加副作用的风险，因此需要在疗效和安全性之间取得平衡。总的来说，适当的分割合计和剂量调整是提高HDR后装治疗在宫颈癌患者中5年疗效的关键因素。"
}